secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2022-01-19T23:59:59+00:00
Accession:  0001801170-22-000006
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health General Counsel Gia Lee steps down; Karen Soares named Interim GC
-------------------------------------------------------------------------------

- Gia Lee, General Counsel, steps down effective Jan 19, 2022; Karen Soares named Interim General Counsel.
- Lee receives separation payments: $520k (12 months base salary + prior year bonus), $120k (2021 bonus), $700k special cash bonus for de-SPAC work.
- During 12-month consulting period, Lee gets $10k/month and continued stock option vesting; she may terminate consulting at any time.
- Departure not due to any disagreement; CEO Vivek Garipalli thanked Lee for her contributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117022000006/0001801170-22-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117022000006/clov-20220113.htm
  HTML page:      https://secwatch.observer/filing/0001801170-22-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer